Morphic
-
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
Congratulations to Lilly and Morphic! This acquisition will expand Lilly’s immunology pipeline with oral integrin therapies
-
32亿美元！礼来收购Morphic公司，加强炎症性肠病（IBD）新药研发
热烈祝贺礼来和Morphic公司！该收购将凭借口服整合素疗法扩展礼来的免疫学管线
